|
FAM199X expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.611100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.26619999999356E-05 |
| Normal-vs-Stage2 |
5.923600E-01 |
| Normal-vs-Stage3 |
3.549400E-01 |
| Normal-vs-Stage4 |
1.182430E-01 |
| Stage1-vs-Stage2 |
3.040000E-01 |
| Stage1-vs-Stage3 |
6.357800E-04 |
| Stage1-vs-Stage4 |
9.011000E-01 |
| Stage2-vs-Stage3 |
2.881400E-01 |
| Stage2-vs-Stage4 |
5.311000E-01 |
| Stage3-vs-Stage4 |
1.032810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.768200E-04 |
| Normal-vs-AfricanAmerican |
5.169800E-02 |
| Normal-vs-Asian |
5.657200E-01 |
| Caucasian-vs-AfricanAmerican |
5.858000E-01 |
| Caucasian-vs-Asian |
8.121200E-01 |
| AfricanAmerican-vs-Asian |
9.697800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01139999994804E-06 |
| Normal-vs-Female |
7.350600E-01 |
| Male-vs-Female |
3.398200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.678300E-02 |
| Normal-vs-Extreme_Weight |
6.9690000004119E-07 |
| Normal-vs-Obese |
5.455800E-01 |
| Normal-vs-Extreme_Obese |
8.274400E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.355160E-01 |
| Normal_Weight-vs-Obese |
3.155400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.118000E-01 |
| Extreme_Weight-vs-Obese |
5.138700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.604200E-01 |
| Obese-vs-Extreme_Obese |
3.597000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.914400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.426100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.227600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.205600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.975200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.930400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.221700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.713800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.065600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.093200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.43740000030968E-07 |
| Normal-VS-Type2 PRCC |
3.841400E-01 |
| Normal-VS-KIRP CIMP |
1.925970E-01 |
| Normal-VS-Unclassified PRCC |
4.133000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.737100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.624520E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.084000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.633800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.424600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.216650E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.521500E-03 |
| Normal-vs-N1 |
7.828400E-01 |
| Normal-vs-N2 |
5.454400E-01 |
| N0-vs-N1 |
3.829700E-02 |
| N0-vs-N2 |
8.397800E-01 |
| N1-vs-N2 |
4.689200E-01 |
|
|
